Genetic basis of the K0 phenotype in the Swedish population

Transfusion

Volumn 45, Issue 4, 2005, Pages 545-549

  Wester, Elisabet S ^b   Storry, Jill R ^a   Schneider, Karin ^b   Sojka, Birgitta Nilsson ^b   Poole, Joyce ^b   Olsson, Martin L ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLOOD GROUP KELL SYSTEM; BLOOD GROUP TYPING; BLOOD TRANSFUSION; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE LOCUS; HUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY; SCANDINAVIA; SEROLOGY; SWEDEN;

ALLELES; ALTERNATIVE SPLICING; CODON, NONSENSE; FAMILY HEALTH; FEMALE; GENETICS, POPULATION; HUMANS; INTRONS; KELL BLOOD-GROUP SYSTEM; MALE; PEDIGREE; PHENOTYPE; POINT MUTATION; SWEDEN;

EID: 17044367421     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2005.04283.x     Document Type: Article

References (20)

1. Lee S, Zambas ED, Marsh WL, et al. Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci U S A 1991;88:6353-7.
2. Lee S, Zambas E, Green ED, et al. Organization of the gene encoding the human Kell blood group protein. Blood 1995;85:1364-70.
3. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 2000;37:113-21.
4. Russo D, Redman C, Lee S. Association of XK and Kell blood group proteins. J Biol Chem 1998;273:13950-6.
5. Le Van Kim C, Collec E, Kroviarski Y, et al. Interaction of Kell glycoprotein with the erythroid membrane skeleton. Vox Sang 2002;(Suppl 2)83:26.
6. Ho M, Chelly J, Carter N, et al. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994;77:869-80.
7. Russo D, Wu X, Redman CM, et al. Expression of Kell blood group protein in nonerythroid tissues. Blood 2000;96:340-6.
8. Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood 1999;94:1440-50.
9. Daniels G. Human blood groups. 2nd ed. Oxford: Blackwell Scientific: 2002.
10. Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.
11. Lee S, Russo DC, Reiner AP, et al. Molecular defects underlying the Kell null phenotype. J Biol Chem 2001;276:27281-9.
12. Yu LC, Twu YC, Chang CY, et al. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens. J Biol Chem 2001;276:10247-52.
13. Koda Y, Soejima M, Tsuneoka M, et al. Heterozygosity for two novel null alleles of the KEL gene causes the Kell-null phenotype in a Japanese woman. Br J Haematol 2002;117:220-5.
14. Rowe AW, Borel H, Allen FH Jr. Droplet-frozen sensitized red cells for Gm typing. Vox Sang 1972;22:188-91.
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
16. Avent ND, Martin PG. Kell typing by allele-specific PCR (ASP). Br J Haematol 1996;93:728-30.
17. Irshaid NM, Ramadan S, Wester ES, et al. Phenotype prediction by DNA-based typing of clinically significant blood group systems in Jordanian blood donors. Vox Sang 2002;83:55-62.
18. Lee S, Naime DS, Reid ME, et al. Molecular basis for the high-incidence antigens of the Kell blood group system. Transfusion 1997;37:1117-22.
19. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 1999;96:307-10.
20. Schell T, Kulozik AE, Hentze MW. Integration of splicing, transport and translation to achieve mRNA quality control by the nonsense-mediated decay pathway. Genome Biol 2002;3:REVIEWS1006.